North America Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Diagnostics and Drug Testing), Product (Antibodies, Equipment, Reagents, and Kits), and End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others)
Market Introduction
North America is the largest market for immunohistochemistry, and the US, Canada, and Mexico are the major contributors to the market in this region. The US led the market during forecast period. Immunohistochemistry market growth in the United States is attributed to the rapidly increasing incidence of chronic diseases such as cancer in the country, as well as the growing demand for diagnostics. Immunohistochemistry (IHC) is a widely used technique for cancer diagnosis; it identifies cancer markers in biological tissues selectively. In breast cancer, immunohistochemistry, for example, quantifies the estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2, Ki-67, and p53. According to the Breast Cancer Organization, an estimated 268,600 new cases of invasive breast cancer will be diagnosed in women in the United States in 2019 and approximately 62,930 new cases of non-invasive (in situ) breast cancer will be diagnosed. Thus, as breast cancer becomes more prevalent, the demand for immunohistochemistry is likely to increase. Additionally, this technique is used to diagnose other types of cancer, such as prostate cancer and lung cancer. According to the National Cancer Institute, the country will see 1,735,350 new cancer cases in 2021. Breast cancer, lung and bronchus bronchial cancer, prostate cancer, colon and rectal cancer, melanoma cancer, and liver cancer are the most common types of cancer. Cancer incidences are increasing at an alarming rate in the country, resulting in an increase in demand for cancer diagnosis. Growing incidences of chronic and infectious diseases and rising R&D investments by biotechnology & biopharmaceutical companies are the major factor driving the growth of the North America immunohistochemistry market.
Countries in North America, especially the US, are highly affected due to the COVID-19 outbreak. Various healthcare research centers across the country are focused on COVID-19 treatments. The outbreak pandemic has adversely affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increasing demand for invitro diagnostic products and rising research and development activities in North America. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out amid the outbreak and delayed or prolonged procurement of equipment. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches are expected to pave the way for entirely virtual trials in the future. New technologies, such as mRNA, are expected to drive the pharmaceutical industry. Thus, the market is expected to witness vertical integration and joint ventures in coming years.
Get more information on this report :
Market Overview and Dynamics
The North America immunohistochemistry market is expected to grow from US$ 838.05 million in 2021 to US$ 1,405.86 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028. The emerging markets across the region are creating significant opportunities for the key market players to expand their business. It is likely to be a prime factor contributing to the market growth during the coming years. Majority of the players concentrate on developing markets, owing to the large population suffering from chronic diseases in the region. With rising costs of production against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in some growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry scope. Advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of a more significant number of immunoassay systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in the region. There has been an increase in the healthcare expenditure of the countries during the previous years. Various players in the industry have been investing a significant amount of their revenue in research and development activities for the development of better and advanced products and technologies to be used in the healthcare industry. Presence of significant biopharmaceutical companies in the region and the growing number of local companies are the factors contributing to the market growth in the region. These activities in the region are increasing the demand for immunohistochemistry. Thus, the rising number of infectious disease incidences and advancements in emerging countries are likely to boost the market and are anticipated to provide significant growth opportunities to the players operating in the North America market during the forecast period.
Key Market Segments
In terms of product, the antibodies segment accounted for the largest share of the North America immunohistochemistry market in 2020. In terms of application, the diagnostics segment held a larger market share of the North America immunohistochemistry market in 2020. Further, the hospitals and diagnostic laboratories segment held a larger share of the North America immunohistochemistry market based on end user in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the North America immunohistochemistry market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abcam plc; Agilent Technologies, Inc.; Bio SB; BIO-RAD LABORATORIES INC.; Cell Signaling Technology, Inc.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; and THERMO FISHER SCIENTIFIC INC.
Reasons to buy report
- To understand the North America immunohistochemistry market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America immunohistochemistry market
- Efficiently plan M&A and partnership deals in North America immunohistochemistry market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America immunohistochemistry market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Immunohistochemistry Market Segmentation
North America Immunohistochemistry Market - By Product
- Equipment
- Slide Staining Systems
- Tissue Microarray Systems
- Tissue Processing Systems
- Slide Scanners
- Other Equipment
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Histological Stains
- Blocking and Fixation Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
North America Immunohistochemistry Market - By Application
- Diagnostics
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Others
- Drug Testing
North America Immunohistochemistry Market - By End User
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
North America Immunohistochemistry Market - By Country
- US
- Canada
- Mexico
North America Immunohistochemistry Market - Company Profiles
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Immunohistochemistry Market – By Product
1.3.2 North America Immunohistochemistry Market – By Application
1.3.3 North America Immunohistochemistry Market – By End User
1.3.4 North America Immunohistochemistry Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Immunohistochemistry Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Immunohistochemistry Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Incidences of Chronic and Infectious Diseases
5.1.2 Rising R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Complexities Associated with Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Several Countries
5.4 Future Trends
5.4.1 Rise of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunohistochemistry Market – North America Analysis
6.1 North America Immunohistochemistry Market Revenue Forecast and Analysis
7. North America Immunohistochemistry Market Analysis– By Product
7.1 Overview
7.2 North America Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3 Antibodies
7.3.1 Overview
7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.3 Primary Antibodies
7.3.3.1 Overview
7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.4 Secondary Antibodies
7.3.4.1 Overview
7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Equipment Market
7.4.1 Overview
7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 Slide Staining Systems
7.4.3.1 Overview
7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Tissue Microarrays
7.4.4.1 Overview
7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Tissue Processing Systems
7.4.5.1 Overview
7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Slide Scanners
7.4.6.1 Overview
7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Other Equipments
7.4.7.1 Overview
7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Reagents Market
7.5.1 Overview
7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.3 Histological Stains
7.5.3.1 Overview
7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.4 Blocking Sera & Reagents Market
7.5.4.1 Overview
7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.5 Chromogenic Substrates Market
7.5.5.1 Overview
7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.6 Stabilizers
7.5.6.1 Overview
7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.7 Proteolytic Enzymes
7.5.7.1 Overview
7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.8 Organic Solvents
7.5.8.1 Overview
7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.9 Fixation Reagents
7.5.9.1 Overview
7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.10 Diluents
7.5.10.1 Overview
7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Kits Market
7.6.1 Overview
7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
8. North America Immunohistochemistry Market Analysis – By Application
8.1 Overview
8.2 North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3 Cancer
8.3.3.1 Overview
8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4 Infectious Diseases
8.3.4.1 Overview
8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5 Autoimmune Diseases
8.3.5.1 Overview
8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6 Diabetes Mellitus
8.3.6.1 Overview
8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7 Nephrological Diseases
8.3.7.1 Overview
8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8 Others
8.3.8.1 Overview
8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Drug Testing
8.4.1 Overview
8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Global Immunohistochemistry Market Analysis– By End User
9.1 Overview
9.2 North America Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3 Hospital & Diagnostic Laboratories
9.3.1 Overview
9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Research Institutes
9.4.1 Overview
9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Others
9.5.1 Overview
9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10. North America Immunohistochemistry Market – Country Analysis
10.1 North America Immunohistochemistry Market Revenue and Forecasts To 2028
10.1.1 North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.1.2.1 US Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.1.2.2 US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.1.2.3 US Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.1.3 US Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.1.3.1 US Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.1.4 US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.1.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.2.2.1 Canada Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.2.2.2 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.2.2.3 Canada Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.2.3 Canada Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.2.3.1 Canada Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.2.4 Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.1.3 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.1 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.3.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.3.2.1 Mexico Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.3.2.2 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.3.2.3 Mexico Antibodies Market Revenue and Forecasts To 2028, By Type (US$ Mn)
10.1.1.3.3 Mexico Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.3.3.1 Mexico Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.3.4 Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on North America Immunohistochemistry Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic developments
12.3.1 Overview
13. Company Profiles
13.1 Cell Signaling Technology, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MERCK KGaA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 THERMO FISHER SCIENTIFIC INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Abcam plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Agilent Technologies, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 BIO-RAD LABORATORIES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Danaher
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Bio SB
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Table 2. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. US Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 4. US Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 5. US Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6. US Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 7. US Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 8. US Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 9. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10. Canada Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 11. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 12. Canada Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13. Canada Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 14. Canada Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 15. Canada Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 16. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. Mexico Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 18. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 19. Mexico Antibodies Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 20. Mexico Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 21. Mexico Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 22. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 23. Organic Developments Done By Companies
Table 24. Inorganic developments done by Companies
Table 25. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Immunohistochemistry Market Segmentation
Figure 2. North America Immunohistochemistry Market Segmentation, By Country
Figure 3. North America Immunohistochemistry Market Overview
Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to North America Immunohistochemistry Market
Figure 8. North America Immunohistochemistry Market – Revenue Forecast and Analysis
Figure 9. North America Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 10. North America Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. North America Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. North America Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. North America Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. North America Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. North America Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. North America Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. North America Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. North America Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. North America Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. North America Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 30. North America Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. North America Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32. North America Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33. North America Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 34. North America Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35. North America Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 36. North America Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 37. North America Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 38. North America Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 39. North America Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. North America Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. North America Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. North America Immunohistochemistry Market Revenue Overview, by Country (2021) (US$ Mn)
Figure 43. North America Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. US Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. Canada Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46. Mexico Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. Impact of COVID-19 Pandemic in North American Country Markets
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America immunohistochemistry market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution